Akari Therapeutics (AKTX) Profit After Tax (2014 - 2026)

Akari Therapeutics (AKTX) posted Profit After Tax of -$14.5 million for Q1 2026, down 172.84% sequentially from -$5.3 million in Q4 2025, and down 290.15% YoY from $7.6 million in Q1 2025.

Akari Therapeutics (AKTX) Profit After Tax (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 9 years of Profit After Tax data on file, last reported at -$14.5 million in Q1 2026.

  • Quarterly Profit After Tax fell 290.15% year-over-year to -$14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.0 million (up 81.8% YoY) and the FY2025 annual result came in at -$17.3 million, up 12.6% from the prior year.
  • Profit After Tax slipped to -$14.5 million in Q1 2026 per AKTX's latest filing, from -$5.3 million in the prior quarter.
  • The five-year high for Profit After Tax was $1.0 million in Q1 2023, with the low at -$140.0 million in Q4 2024.
  • Average Profit After Tax over 4 years is -$15.2 million, with a median of -$4.1 million recorded in 2023.
  • Year-over-year, Profit After Tax sank 3283.11% in 2024 and jumped 96.22% in 2025.
  • Akari Therapeutics' Profit After Tax stood at -$4.1 million in 2023, then slumped by 3283.11% to -$140.0 million in 2024, then jumped by 96.22% to -$5.3 million in 2025, then plunged by 172.84% to -$14.5 million in 2026.
  • Business Quant data shows AKTX's Profit After Tax at -$14.5 million in Q1 2026, -$5.3 million in Q4 2025, and -$6.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 53.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -14.46 Mn
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 227.36 Mn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 1.03 Bn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -4.45 Mn
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 727.20 Mn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 378.00 Mn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 205.99 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn - -453.82 Mn
10 Moderna 28.64 Bn 23.43 Bn -566.00 Mn -1.34 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.46 Mn
Dec 31, 2025 -5.30 Mn
Sep 30, 2025 -6.40 Mn
Jun 30, 2025 -1.90 Mn
Mar 31, 2025 -3.71 Mn
Dec 31, 2024 -139.99 Mn
Sep 30, 2024 -2.90 Mn
Jun 30, 2024 -7.56 Mn
Mar 31, 2024 -5.57 Mn
Dec 31, 2023 -4.14 Mn
Sep 30, 2023 -2.87 Mn
Jun 30, 2023 -4.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2020 -6.81 Mn
Sep 30, 2020 913,454.00
Jun 30, 2020 -7.44 Mn
Mar 31, 2020 -3.75 Mn
Dec 31, 2019 -7.83 Mn
Sep 30, 2019 -2.88 Mn
Jun 30, 2019 -5.95 Mn